McAdam LLC’s Medical Properties Trust MPT Stock Holding History

McAdam LLC’s Portfolio MPT Stock Details MPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-196	Closed	-$3K	–	745
2018 Q1	$3K	Buy	+196	New	+$2.51K	﹤0.01%	480

Other funds holding MPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

McAdam LLC's MPT Position: Q2 2018 in Review

McAdam LLC sold out of Medical Properties Trust (MPT) in Q2 2018, closing a stake of 196 shares — an estimated $3K sold.

McAdam LLC first reported a position in MPT in Q1 2018 and held it in 1 quarter. The position peaked at $3K in Q1 2018. 366 funds tracked by Wall St. Rank hold MPT as of Q2 2018.

McAdam LLC reported no remaining Medical Properties Trust position as of Q2 2018 after selling out during the quarter.
McAdam LLC sold 196 Medical Properties Trust shares in Q2 2018, an estimated $3K.
McAdam LLC first reported a position in Medical Properties Trust in Q1 2018 and held it in 1 quarter.
McAdam LLC's Medical Properties Trust position peaked at $3K in Q1 2018.
366 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2018.

Based on McAdam LLC's 13F filing for Q2 2018, filed 22 Aug 2018.